NOVEL NUTRACEUTICAL COMPOUNDS IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEUROLOGICAL DISORDERS

Alzheimer's disease (AD), which affects up to 50 million people globally today, is one of the biggest mysteries in medical science and public health systems. This complex brain condition is characterized by apathy, mood and neuropsychiatric abnormalities, as well as gradual cognitive impairment. Ageing is the primary risk factor for AD; it is a normal biologicalprocedure connected to a continuous dynamic that involves a progressive loss of people's physical capabilities, but with a reliable, lived-in perspective on life. According to studies, AD differs from healthy ageing in that it causes changes in the processes that safeguard neurons as well as their powerful functioning capabilities. Given the components of nutrition, regular exercise, and avoiding certain substances, a significant route has been created towards preventing AD in this environment. Avoiding harmful chemicals and narcotics, maintaining an active social life, engaging in meditation, and managing stress are all necessary for healthy ageing. Here, we examine how these elements are involved and how to reduce environmental risk factors for a higher standard of living. both proactive and creative, the use of trustworthy biomarkers in screening programs for early disease identification is becoming increasingly important for disease management.Additionally, the failure of conventional pharmaceutical therapies and the search for new medications have sparked the development of nutraceutical compounds in the context of "multi-target" therapy, as well as mindfulness techniques that are effective in the management of AD and ageing.All of these preventive measures combined with cutting-edge pharmaceutical techniques should form the basis of an integrated strategy for the eventual control of the illness. According to studies, AD is different from healthy ageing in that it causes alterations in the processes that safeguard neurons while maintaining their great functioning capabilities. Given that daily exercise, healthy eating, and avoiding harmful chemicals are all critical components of AD prevention, an important road has been opened in this regard.drugs, a bustling social life, meditation, and stress management are all necessary for good ageing. Here, we examine how these elements are involved and how to reduce risk factors from the environment for a higher standard of living. The control of the illness is increasingly dependent on prevention as well as cutting-edge screening programmes for early diagnosis of the disease utilizing accurate biomarkers. Additionally, the ineffectiveness of conventional pharmaceutical therapies and the quest for novel medicationshas sparked the development of nutraceutical substances in the framework of a "multitarget" therapy, as well as methods of mindfulness that have been shown useful for the management of ageing and AD. All of these protective factors coupled with an integrated strategy,The future management of the condition should be made possible by innovative pharmaceutical techniques.